These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6132474)

  • 1. [Thrombocyte aggregation and fibrinolytic activity during long-term beta-block therapy].
    Jürgensen HJ; Nielsen JD; Gormsen J; Kjøller E
    Ugeskr Laeger; 1982 Nov; 144(47):3489-92. PubMed ID: 6132474
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of beta-blockade on platelet function and fibrinolytic activity.
    Winther K
    J Cardiovasc Pharmacol; 1987; 10 Suppl 2():S94-8; discussion S99. PubMed ID: 2481178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of long-term beta-blockade with alprenolol on platelet function and fibrinolytic activity in patients with coronary heart disease.
    Jürgensen HJ; Dalsgaard-Nielsen J; Kjøller E; Gormsen J
    Eur J Clin Pharmacol; 1981; 20(4):245-50. PubMed ID: 7030749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of medical therapy on long-term survival in ischemic heart disease].
    Caruzzo C; Sechi A; Monti C; Campagna G; Spinnler MT
    Minerva Cardioangiol; 1984 Dec; 32(12):887-93. PubMed ID: 6152332
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effects of nitrates and beta-blockers on platelet aggregation in patients with coronary heart disease].
    Wlazłowski R; Kruszyński G; Goch JH
    Pol Merkur Lekarski; 2000 Feb; 8(44):77-9. PubMed ID: 10808734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of Complamin on fibrinolysis and platelet aggregation in the aged].
    Matijević N; Sisić I; Korolija P; Pendić B
    Bilt Hematol Transfuz; 1980; 8(1):37-43. PubMed ID: 7337681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thrombocytic hemostasis in the complex treatment of patients with ischemic heart disease].
    Khimenko PL; Nikitin AE
    Vrach Delo; 1985 May; (5):53-6. PubMed ID: 2861693
    [No Abstract]   [Full Text] [Related]  

  • 8. [Current problems in the conservative long-term treatment of ischemic heart disease].
    Urbaszek W; Modersohn D; Schauer J; Günther K
    Z Arztl Fortbild (Jena); 1976 Jan; 70(1):2-13. PubMed ID: 9744
    [No Abstract]   [Full Text] [Related]  

  • 9. [The value of drug therapy in coronary disease].
    Stauch M
    ZFA (Stuttgart); 1979 Oct; 55(28):1577. PubMed ID: 44408
    [No Abstract]   [Full Text] [Related]  

  • 10. Determinants of thrombin generation, fibrinolytic activity, and endothelial dysfunction in patients on dual antiplatelet therapy: involvement of factors other than platelet aggregability in Virchow's triad.
    Yano Y; Ohmori T; Hoshide S; Madoiwa S; Yamamoto K; Katsuki T; Mitsuhashi T; Mimuro J; Shimada K; Kario K; Sakata Y
    Eur Heart J; 2008 Jul; 29(14):1729-38. PubMed ID: 18270211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of the action of beta adrenergic blocking agents on platelet adhesiveness and fibrinolysis in atherosclerosis].
    Nicolaescu V; Ionăşescu R; Pompilian P; Teodorescu P
    Med Interna (Bucur); 1970 Dec; 22(12):1497-503. PubMed ID: 4396020
    [No Abstract]   [Full Text] [Related]  

  • 12. Follow-up of hemorheological parameters and platelet aggregation in patients with acute coronary syndromes.
    Marton Z; Horvath B; Alexy T; Kesmarky G; Gyevnar Z; Czopf L; Habon T; Kovacs L; Papp E; Mezey B; Roth E; Juricskay I; Toth K
    Clin Hemorheol Microcirc; 2003; 29(2):81-94. PubMed ID: 14610303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of glipizide on platelet function and fibrinolytic activity.
    Ketsa K; Jererat S; Nitiyanant W; Suwanwattana K
    J Med Assoc Thai; 1987 Oct; 70(10):578-82. PubMed ID: 3694080
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of alprenolol in coronary disease].
    Tricot R; Valère PE
    Ann Med Interne (Paris); 1971 Feb; 122(2):233-6. PubMed ID: 4397123
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of hyperlipoproteinemia on blood fibrinolytic activity and thrombocyte aggregation].
    Kostić N; Secen S
    Med Pregl; 2000; 53(3-4):180-3. PubMed ID: 10965685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intrinsic sympathomimetic activity of adrenergic beta receptor blockaders and its role in various clinical situations].
    Bubiński R
    Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1713-6. PubMed ID: 6151656
    [No Abstract]   [Full Text] [Related]  

  • 17. [Importance of thrombocyte aggregation in altering the fibrinolytic activity and nonenzymatic fibrinolysis of the blood plasma].
    Pastorova VE; Bazaz'ian GG; Romanovskiĭ AA
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1982; (8):58-61. PubMed ID: 6215958
    [No Abstract]   [Full Text] [Related]  

  • 18. [Secondary prevention of myocardial infarct].
    Kotsev G
    Vutr Boles; 1984; 23(2):55-9. PubMed ID: 6146228
    [No Abstract]   [Full Text] [Related]  

  • 19. [Inhibition of thrombocyte aggregation by beta blockers. Reduction of collagen-induced thrombocyte aggregation in vitro].
    Schulz V
    Fortschr Med; 1984 Dec; 102(47-48):1203-5. PubMed ID: 6151541
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of D-thyroxine on fibrinolysis and on platelet adhesiveness and aggregation in arteriosclerotic subjects].
    Cajozzo A; Citarrella P; Abbadessa V; Di Marco P
    Boll Soc Ital Biol Sper; 1974 Aug; 50(13):984-90. PubMed ID: 4463990
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.